AnaptysBio, Inc. ANAB Biopharma Company — Income Tax Expense Benefit

Other segment segments

Similar metrics at other companies

SYREIncome Tax

$0+100%

GRDNCorporate — Income Tax Expense Benefit

$4.75M+23.9%

FHBCorporate And Other Nonoperating — Income Tax Expense Benefit

-$7.1M+11.6%

NBT

NBTBBanking — Income Tax Expense Benefit

$14.02M+54.9%

COPCorporate — Income tax provision (benefit)

-$119M-222%

QCRHCommercial Banking — Income Tax Expense Benefit

$1.97M+119%

Questions, answered.

What is AnaptysBio, Inc.'s biopharma company — income tax expense benefit?

AnaptysBio, Inc. (ANAB) reported biopharma company — income tax expense benefit of $0 in Q1 2026.

What does biopharma company — income tax expense benefit mean?

This metric represents the total income tax provision or benefit recognized by the biopharma business segment during the reporting period. It reflects the impact of tax regulations on the segment's financial performance, including deferred tax assets and liabilities. For clinical-stage companies, this is often zero due to consistent operating losses.